A BUSINESS BUILT ON
THE PURSUIT OF UNUSUAL, RISK ADJUSTED PERFORMANCE


Katherine Priestley
Managing Director

Katherine is the Managing Director of Park Vale. Katherine has experience throughout the US, Europe, and Asia in finance, consulting, M&A, and business operations. Katherine’s business experience in Asia began early in her career working for Chuo Coopers, a US/Japanese JV in M&A focused on the finance industry during the later part of 1980s.

More recently she has worked for a family investment office where she was responsible for advising on asset allocation, manager selection, and risk management with a strong focus on alternative assets. Katherine also has experience in managing companies, having served as Finance Director of a UK industrial company.

Katherine currently serves as a Board Director of the Pitblado Foundation, Trustee of the Krazna Krauz Foundation, a member of the Advisory Committee for the Royal Society, and has a strong working relationship with the Academy of Medical Sciences. Katherine received her B.A. Honours from Newcastle-Upon-Tyne University, UK and Kokusai Kirisutokyo Daigaku (ICU) Tokyo, Japan; and her MBA from Columbia University, US.

Back To Overview

Biotechnology Investments

The Park Vale Capital biotechnology team is currently focusing on investments in companies engaged in late stage biotechnology and pharma development selected from their extensive network of deal flow.